96 related articles for article (PubMed ID: 17560284)
1. New technologies used in the study of human melanoma.
Felsani A; Mileo AM; Maresca V; Picardo M; Paggi MG
Int Rev Cytol; 2007; 261():247-86. PubMed ID: 17560284
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling and clinical outcome in melanoma: in search of novel prognostic factors.
Winnepenninckx V; van den Oord JJ
Expert Rev Anticancer Ther; 2007 Nov; 7(11):1611-31. PubMed ID: 18020928
[TBL] [Abstract][Full Text] [Related]
3. Systematic search for the best gene expression markers for melanoma micrometastasis detection.
Soikkeli J; Lukk M; Nummela P; Virolainen S; Jahkola T; Katainen R; Harju L; Ukkonen E; Saksela O; Hölttä E
J Pathol; 2007 Oct; 213(2):180-9. PubMed ID: 17891747
[TBL] [Abstract][Full Text] [Related]
4. Novel biomarkers in malignant melanoma.
Bosserhoff AK
Clin Chim Acta; 2006 May; 367(1-2):28-35. PubMed ID: 16480699
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of human melanoma cell lines with distinct metastatic potential identifies new progression markers.
Bertucci F; Pages C; Finetti P; Rochaix P; Lamant L; Devilard E; Nguyen C; Houlgatte R; Birnbaum D; Xerri L; Brousset P
Anticancer Res; 2007; 27(5A):3441-9. PubMed ID: 17970093
[TBL] [Abstract][Full Text] [Related]
6. Identification of new genes associated with melanoma.
Mauerer A; Roesch A; Hafner C; Stempfl T; Wild P; Meyer S; Landthaler M; Vogt T
Exp Dermatol; 2011 Jun; 20(6):502-7. PubMed ID: 21410771
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis.
Martins I; Sylla K; Deshayes F; Lauriol J; Ghislin S; Dieu-Nosjean MC; Viguier M; Verola O; Charron D; Alcaide-Loridan C; Al-Daccak R
Melanoma Res; 2009 Aug; 19(4):226-37. PubMed ID: 19574933
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of nuclear ING3 expression in human cutaneous melanoma.
Wang Y; Dai DL; Martinka M; Li G
Clin Cancer Res; 2007 Jul; 13(14):4111-6. PubMed ID: 17634537
[TBL] [Abstract][Full Text] [Related]
9. Melanoma progression, gene expression and DNA microarrays.
Hoek KS
G Ital Dermatol Venereol; 2009 Feb; 144(1):39-49. PubMed ID: 19218910
[TBL] [Abstract][Full Text] [Related]
10. Applications of array technology: melanoma research and diagnosis.
Nambiar S; Mirmohammadsadegh A; Bär A; Bardenheuer W; Roeder G; Hengge UR
Expert Rev Mol Diagn; 2004 Jul; 4(4):549-57. PubMed ID: 15225102
[TBL] [Abstract][Full Text] [Related]
11. Novel MITF targets identified using a two-step DNA microarray strategy.
Hoek KS; Schlegel NC; Eichhoff OM; Widmer DS; Praetorius C; Einarsson SO; Valgeirsdottir S; Bergsteinsdottir K; Schepsky A; Dummer R; Steingrimsson E
Pigment Cell Melanoma Res; 2008 Dec; 21(6):665-76. PubMed ID: 19067971
[TBL] [Abstract][Full Text] [Related]
12. PAX4 has the potential to function as a tumor suppressor in human melanoma.
Hata S; Hamada J; Maeda K; Murai T; Tada M; Furukawa H; Tsutsumida A; Saito A; Yamamoto Y; Moriuchi T
Int J Oncol; 2008 Nov; 33(5):1065-71. PubMed ID: 18949370
[TBL] [Abstract][Full Text] [Related]
13. Melanoma genomics reveals signatures of sensitivity to bio- and targeted therapies.
Tímár J; Mészáros L; Ladányi A; Puskás LG; Rásó E
Cell Immunol; 2006 Dec; 244(2):154-7. PubMed ID: 17433276
[TBL] [Abstract][Full Text] [Related]
14. [A trip through the signaling pathways of melanoma].
Fensterle J
J Dtsch Dermatol Ges; 2006 Mar; 4(3):205-17. PubMed ID: 16626317
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-221 and -222 pathway controls melanoma progression.
Felicetti F; Errico MC; Segnalini P; Mattia G; Carè A
Expert Rev Anticancer Ther; 2008 Nov; 8(11):1759-65. PubMed ID: 18983236
[TBL] [Abstract][Full Text] [Related]
16. A new piece in the melanoma mosaic--carcinosarcoma-like melanoma.
Svec A; Wilkinson L; Bury Y; Martin VG
Histopathology; 2009 Sep; 55(3):366-8. PubMed ID: 19723157
[No Abstract] [Full Text] [Related]
17. Markers of melanogenesis in malignant melanoma.
Matous B; Bubnova E; Budesinska A; Kostirova M
Sb Lek; 1994; 95(4):333-38. PubMed ID: 8867704
[TBL] [Abstract][Full Text] [Related]
18. HER3 is a determinant for poor prognosis in melanoma.
Reschke M; Mihic-Probst D; van der Horst EH; Knyazev P; Wild PJ; Hutterer M; Meyer S; Dummer R; Moch H; Ullrich A
Clin Cancer Res; 2008 Aug; 14(16):5188-97. PubMed ID: 18698037
[TBL] [Abstract][Full Text] [Related]
19. Expression of nm23-H1 in uveal melanoma.
Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
[TBL] [Abstract][Full Text] [Related]
20. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S
Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
